Full Text
PCSK9 Inhibitors May Improve Cardiovascular Outcomes- Can We Afford Them?

Abstract

Authors

R Arbel A Hammerman N Triki D Greenberg

Back to Volume 19, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×